Compare ARK Genomic Revolution ETF (ARKG) vs Vanguard Total Stock Market Index Fund ETF (VTI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Vanguard Total Stock Market Index Fund ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.55, while Vanguard Total Stock Market Index Fund ETF trades at $369.65. Which is the better fit depends on your goals.
| ARKG | VTI | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $374.36 |
52-Week Low | $23.09 | $305.74 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
VTI trades at $372.69, up 0.33% with a bullish technical signal from moving averages. The ETF provides diversified exposure to the entire U.S. stock market with over 3,400 holdings. Recent news highlights VTI's historical 10% annual returns and its inclusion in new tax-advantaged investment accounts. Technical indicators show support at $369 and resistance at $373, with RSI levels in neutral territory suggesting balanced momentum.
VTI offers broad market diversification at minimal cost (0.03% expense ratio), making it attractive for long-term investors. Key risks include market-wide volatility and economic uncertainty. Analyst sentiment remains positive given VTI's comprehensive exposure and low-cost structure, though investors should monitor broader economic indicators that could impact overall market performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Vanguard Total Stock Market Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the index, which represents approximately 100% of the investable US stock market and includes large-, mid-, small-, and micro-cap stocks. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.
Read more on VTI →
